Matthew Davey

Aug 11, 2023 | mdpi.com | Raza Syed |Matthew Davey |Vinitha Richard |Nic Annette Miller

1. IntroductionOne in eight women worldwide will be diagnosed with breast cancer [1], with the disease representing the most common cause of cancer-related death in women [2]. Therefore, it is imperative that further translational research efforts focus on adding novel diagnostic and therapeutic tools to the clinician’s armamentarium. Breast cancer is typically classified into four intrinsic subtypes, including Luminal A, Luminal B, Erb-B2 overexpressing, and “basal-like” [3].